COMMUNIQUÉS West-GlobeNewswire

Ligand to Participate in November Investor Conferences
30/10/2025
JUPITER, Fla., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza will participate in [...]
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
30/10/2025
-- Webcast event to begin at 8:00am ET on Wednesday, November 12, 2025 -- CAMBRIDGE, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new [...]
Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics
30/10/2025
Reports Q3 revenue of $993.7 million, up 43.5% year-over-year Beats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit and adjusted EBITDA [...]
Galapagos Announces Changes to its Board to Accelerate Strategic Focus on Business Development
30/10/2025
New Directors bring strong financial leadership, capital allocation, and business development expertise to the Board Mechelen, Belgium; October 30, 2025, 21:01 CET — Galapagos NV (Euronext & NASDAQ: GLPG), today [...]
Liminatus Pharma, Inc. (NASDAQ: LIMN) Signs MOU with Capital Trust Group for USD 30 Million Equity Investment via an earn-out mechanism and Future Strategic Cooperation
30/10/2025
LA PALMA, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Liminatus Pharma, Inc. (NASDAQ: LIMN), a clinical-stage immuno-oncology company developing next-generation CD47-blockade therapies, announced today that it has entered [...]
11 New Living Soil THCA Strains Now Available at The Hemp Doctor
30/10/2025
MOORESVILLE, N.C., Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Hemp Doctor, a leader in offering premium hemp-derived products, has expanded its THCA flower collection with 11 new strains grown in living soil. This [...]
Abeona Therapeutics® Announces Permanent J-Code for ZEVASKYN® (prademagene zamikeracel)
30/10/2025
CLEVELAND, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases, today announced that the [...]
Resuscitec’s CARL® ECPR System Wins the Prix Galien USA 2025 “Best Startup” Award
30/10/2025
Industry’s top honor recognizes Resuscitec’s life-restoring technology redefining outcomes after sudden cardiac arrest NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Resuscitec GmbH today announced that its CARL® ECPR [...]
Good Samaritan President and CEO Honoured Among Canada’s Most Powerful Women
30/10/2025
EDMONTON, Alberta, Oct. 30, 2025 (GLOBE NEWSWIRE) -- The Good Samaritan Society and Good Samaritan Canada (Good Samaritan) are proud to announce that Dr. Katherine Chubbs, President and CEO, has been named one of Canada [...]
Wounded Warriors Family Support, AMVET Power Announce Strategic Partnership to Empower Veterans
30/10/2025
OMAHA, Neb., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Wounded Warriors Family Support and AMVET Power have announced a new charity partnership dedicated to enhancing support for our nation's wounded veterans, their families [...]
Psychologie Berlin's Dr. Dirk Stemper Announces New Book: The Vagus Nerve: Why You Don’t Need a Reset – Real Neuromodulation for Exhaustion, Trauma, and Long COVID
30/10/2025
New book reveals evidence-based approaches for nervous system dysfunction—debunking quick fixes and offering actionable strategies in neuromodulation, biofeedback, and trauma recovery. Vagus Nerve—Science, Not Myth: Dr [...]
Informations relatives au nombre total de droits de vote et d’actions composant le capital
30/10/2025
Informations relatives au nombre total de droits de vote et d’actions composant le capital Nantes, le 30 octobre 2025 – En application de l’article L. 233-8 II du Code de commerce et de l’article 223-16 du Règlement [...]
Glass House Brands to Host Third Quarter 2025 Earnings Call on November 12, 2025
30/10/2025
LONG BEACH, Calif. and TORONTO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest- [...]
23andMe Research Institute Appoints Privacy Advisory Board
30/10/2025
PALO ALTO, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- 23andMe Research Institute, a nonprofit medical research organization, today announced the formation of its Privacy Advisory Board. Composed of leading experts in [...]
Lisata Therapeutics to Report Third Quarter 2025 Financial Results and Provide a Business Update on Thursday, November 6, 2025
30/10/2025
BASKING RIDGE, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of [...]
MediBeacon to Present at the Upcoming American Society of Nephrology (ASN) Kidney Week 2025
30/10/2025
ST. LOUIS, Oct. 30, 2025 (GLOBE NEWSWIRE) -- MediBeacon Inc. , a medical technology company specializing in the advancement of fluorescent tracer agents and their transdermal detection, today announced that data from [...]
New Clinical and Translational Data on PDS Biotechnology’s Novel Investigational Cancer Therapies PDS0101 and PDS01ADC to be Presented at the 2025 Society for Immunotherapy of Cancer (SITC) Annual Meeting
30/10/2025
Three abstracts accepted for presentation, including one rapid oral abstract session Presentations to highlight ongoing clinical and translational research across PDS Biotechnology’s immunotherapy platforms PRINCETON, N [...]
Veru Announces Pricing of $25 Million Public Offering
30/10/2025
MIAMI, FL, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the treatment of cardiometabolic and inflammatory [...]
BioCardia Announces University of Wisconsin Enrolls Their First Patient in Phase 3 CardiAMP HF II Cell Therapy Pivotal Trial
30/10/2025
SUNNYVALE, Calif., Oct. 30, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. [NASDAQ: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announced [...]

Pages